Zusammenfassung
In Anbetracht der demographischen Entwicklung mit einem Anstieg der älteren Bevölkerung werden auch bei Patienten in einem fortgeschrittenen Lebensalter andrologische Gesichtspunkte zunehmend bedeutender. Die mittlere Lebenserwartung eines Mannes stieg in den letzten 100 Jahren von 44,8 Jahren auf 74,4 Jahre.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Becker AJ, Ückert S, Stief CG (2008) Grundlagen der Phosphodiesterase-5-(PDE5-)Inhibitoren. Urologe 47:1582–1587
Brandenburg U, Sperling H, Hartmann U et al (2002) Sexualität im Alter. Urologe 41:346–349
Chung E, Brock GB (2011) A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases. Expert Opin Pharmacother 12:1341
Curran M, Keating G (2003) Tadalafil. Drugs 63:2203
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral Sildenafil in the treatment of erectile dysfunction. J Urol 167:1197–1203
Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, DiDonato K, Trask B, Day WW (2012) A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med 9:1122–1133
Guay AT, Perez JB, Velasquez E, Newton RA, Jacobson JP (2000) Clinical experience with intraurethral alprostadil (MUSE®) in the treatment of men with erectile dysfunction. Eur Urol 38:671–676
Guiliano F, Rubio-Auroiles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH (2006) Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 66:201–216
Guiliano F, Sanchez-Ramos A, Lochner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J (2007) Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 64:1584–1592
Kim SC, Ahn TY, Choi HK, Chung TG, Chung WS, Hwang TK, Hyun JS, Jung GW, Kim CI, Kim JJ, Lee CH, Lee KS, Lee WH, Min KS, Moon KH, Paic JS, Park KS, Park NC, Park YK, Seo JK, Seo KK, Shin JS, Yoon YR, Lee WC (2000) Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Int J Impot Res 12:97–101
Lea AP, Bryson HM, Balfour JA (1996) Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction. Drugs Aging 8:56–74
Linet OI, Ogrinc FG (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med 334:873–877
Moncada I, Cuzin B (2015) Clinical efficacy and safety of Vitaros©/Virirec© (Alprostadil cream) for the treatment of erectile dysfunction. Urologia 82:84–92
Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, DiDonato K, Shih W, Day WW (2013) A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol 189:2229–2236
Padma-Nathan H, Yeager JL (2006) An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients. Urology 68:386–391
Roehrborn CG, Egan KB, Miner MM, Ni X, Wong DG, Rosen RC (2016) Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment. BJU 118:153–160
Sperling H, Jockenhövel F, Stackl W et al (2006) LOH (late onset hypogonadism) oder „aging male“. Urologe 45:163–168
Wayne J, Hellstrom G, Elhilali M, Homering M, Taylor T, Gittleman M (2005) Vardenafil in patients with erectile dysfunction: achieving treatment optimization. J Androl 26:604–609
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Kaminsky, A., Sperling, H. (2021). Erektile Dysfunktion. In: Merseburger, A.S., Kramer, M.W. (eds) Medikamente in der Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61492-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-61492-1_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-61491-4
Online ISBN: 978-3-662-61492-1
eBook Packages: Medicine (German Language)